Fundraising Fox
Protembis
Aachen, DE · Founded 2013 · 16 employees on LinkedIn · 7 known investors
Find your way into Protembis
Sign up to see every warm intro you have to Protembis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Protembis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Protembis is a German medical device company developing the ProtEmbo Cerebral Protection System, an intra-aortic filter device inserted via the left radial artery that shields the brain from embolic debris during transcatheter aortic valve replacement (TAVR) and other left-sided heart procedures. The device aims to reduce the risk of stroke and cognitive decline for cardiac patients and is undergoing clinical investigation.
Founders & leadership
Investors · 7
How we know: the company's own site · Not right? Tell us
How we know: Seed Fonds Aachen's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: TechVision Fonds's portfolio page · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BMar 2024
Segulah Medical Acceleration (lead), TechVision Fund (lead), XGEN Venture (lead), Coparion
Source ↗ - Undisclosed amountSeries AOct 2018Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Protembis do?
- Protembis is a German medical device company developing the ProtEmbo Cerebral Protection System, an intra-aortic filter device inserted via the left radial artery that shields the brain from embolic debris during transcatheter aortic valve replacement (TAVR) and other left-sided heart procedures. The device aims to reduce the risk of stroke and cognitive decline for cardiac patients and is undergoing clinical investigation.
- Who are Protembis's investors?
- Protembis's investors include European Investment Bank, Seed Fonds Aachen, TechVision Fonds, TechVision Fund, XGEN Venture.
- Where is Protembis headquartered?
- Protembis is headquartered in Aachen, DE.